Published in Cancer Causes Control on November 01, 2005
Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol (2010) 10.70
Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer (2009) 1.74
The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care (2012) 1.42
Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients. Ann Oncol (2011) 1.41
Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study. Prostate (2008) 1.21
Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System. BMC Med (2007) 1.16
Cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan. BMC Cancer (2014) 0.93
Long-term use of angiotensin receptor blockers and the risk of cancer. PLoS One (2012) 0.89
Principles of epidemiological research on adverse and beneficial drug effects. Lancet (1998) 2.53
The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease. Arch Intern Med (1992) 1.98
Statins and risk of polyneuropathy: a case-control study. Neurology (2002) 1.97
Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Arch Intern Med (1996) 1.87
Positive predictive value of ICD-9 codes in the identification of cases of complicated peptic ulcer disease in the Saskatchewan hospital automated database. Epidemiology (1996) 1.87
Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology (1997) 1.68
Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther (2004) 1.61
The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs. Epidemiology (1993) 1.58
Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. BMJ (1997) 1.55
Depression and treatment with antidepressants are associated with the development of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2010) 1.49
Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J Clin Invest (2001) 1.45
Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study. Aliment Pharmacol Ther (2008) 1.44
Risk of myocardial infarction persisting after discontinuation of non-steroidal anti-inflammatory drugs in the general population. J Thromb Haemost (2009) 1.39
[The BIFAP project: database for pharmaco-epidemiological research in primary care]. Aten Primaria (2002) 1.37
Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations. BMC Clin Pharmacol (2001) 1.30
Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer (2006) 1.16
Incidence of newly diagnosed heart failure in UK general practice. Eur J Heart Fail (2001) 1.08
Respiratory medications and risk of asthma death. Thorax (2002) 1.06
Positive predictive value of ICD-9th codes for upper gastrointestinal bleeding and perforation in the Sistema Informativo Sanitario Regionale database. J Clin Epidemiol (1999) 1.01
One-year follow-up of newly diagnosed irritable bowel syndrome patients. Aliment Pharmacol Ther (1999) 0.97
Incidence rates and trends of hip/femur fractures in five European countries: comparison using e-healthcare records databases. Calcif Tissue Int (2014) 0.96
Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study. Pharmacotherapy (1993) 0.94
Uncomplicated peptic ulcer in the UK: trends from 1997 to 2005. Aliment Pharmacol Ther (2009) 0.93
Are schizophrenia or antipsychotic drugs a risk factor for cataracts? Epidemiology (2000) 0.92
Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs? Aliment Pharmacol Ther (2003) 0.91
Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol (1999) 0.91
Liver disease associated with diclofenac, naproxen, and piroxicam. Pharmacotherapy (1992) 0.91
Are users of lipid-lowering drugs at increased risk of peripheral neuropathy? Eur J Clin Pharmacol (2001) 0.89
Use of prescription contraceptive methods in the UK general population: a primary care study. BJOG (2013) 0.84
Overall mortality among patients surviving an episode of peptic ulcer bleeding. J Epidemiol Community Health (2000) 0.83
Presence of diabetes related complication at the time of NIDDM diagnosis: an important prognostic factor. Eur J Epidemiol (1998) 0.82
Antiepileptics and blood dyscrasias: a cohort study. Pharmacotherapy (1999) 0.81
Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population. Heart (2006) 0.81
Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review. Drug Saf (1998) 0.79
Unspecified abdominal pain in primary care: the role of gastrointestinal morbidity. Int J Clin Pract (2007) 0.78
The risk of obstructive airways disease in a glaucoma population. Pharmacoepidemiol Drug Saf (2001) 0.76
Gender and drug treatment as determinants of mortality in a cohort of heart failure patients. Eur J Epidemiol (2001) 0.75
[Epidemiology and the pharmaceutical industry]. Med Clin (Barc) (1992) 0.75
Ocular safety of antiulcer drugs. Lancet (1995) 0.75